U930 "Imaging and Brain", Inserm, Tours, France; UFR Sciences et Techniques, Université François Rabelais, Tours, France.
UFR Sciences et Techniques, Université François Rabelais, Tours, France.
Neuropharmacology. 2017 Nov;126:179-189. doi: 10.1016/j.neuropharm.2017.09.009. Epub 2017 Sep 7.
Major depression is hypothesized to be associated with dysregulations of the hypothalamic-pituitary-adrenal (HPA) axis and impairments in adult hippocampal neurogenesis. Adult-born hippocampal neurons are required for several effects of antidepressants and increasing the rate of adult hippocampal neurogenesis (AHN) before exposure to chronic corticosterone is sufficient to protect against its harmful effects on behavior. However, it is an open question if increasing AHN after the onset of chronic stress exposure would be able to rescue behavioral deficits and which mechanisms might be involved in recovery. We investigated this question by using a 10-week unpredictable chronic mild stress (UCMS) model on a transgenic mouse line (iBax mice), in which the pro-apoptotic gene Bax can be inducibly ablated in neural stem cells following Tamoxifen injection, therefore enhancing the survival of newborn neurons in the adult brain. We did not observe any effect of our treatment in non-stress conditions, but we did find that increasing AHN after 2 weeks of UCMS is sufficient to counteract the effects of UCMS on certain behaviors (splash test and changes in coat state) and endocrine levels and thus to display some antidepressant-like effects. We observed that increasing AHN lowered the elevated basal corticosterone levels in mice exposed to UCMS. This was accompanied by a tamoxifen-induced reversal of the lack of stress-induced decrease in neuronal activation in the anteromedial division of the bed nucleus of the stria terminalis (BSTMA) after intrahippocampal dexamethasone infusion, pointing to a possible mechanism through which adult-born neurons might have exerted their effects. Our results contribute to the neurogenesis hypothesis of depression by suggesting that increasing AHN may be beneficial not just before, but also after exposure to stress by counteracting several of its effects, in part through regulating the HPA axis.
重度抑郁症被假设与下丘脑-垂体-肾上腺(HPA)轴的失调和成年海马神经发生的损伤有关。成年海马神经元是抗抑郁药的多种作用所必需的,并且在暴露于慢性皮质酮之前增加成年海马神经发生(AHN)的速度足以防止其对行为的有害影响。然而,在慢性应激暴露后增加 AHN 是否能够挽救行为缺陷,以及哪些机制可能涉及恢复,这仍然是一个悬而未决的问题。我们使用一种可诱导的转基因小鼠品系(iBax 小鼠)的 10 周不可预测性慢性轻度应激(UCMS)模型来研究这个问题,在该模型中,在他莫昔芬注射后,促凋亡基因 Bax 可以在神经干细胞中被诱导缺失,从而增强成年大脑中新神经元的存活。我们在非应激条件下没有观察到我们的治疗有任何效果,但我们确实发现,在 UCMS 后 2 周增加 AHN 足以抵消 UCMS 对某些行为(飞溅测试和毛色变化)和内分泌水平的影响,从而显示出一些抗抑郁样效果。我们观察到,增加 AHN 可以降低暴露于 UCMS 的小鼠中升高的基础皮质酮水平。这伴随着在海马内给予地塞米松后,内侧前终纹床核(BSTMA)的神经元激活减少,这是由于他莫昔芬诱导的应激诱导减少的逆转,提示了一种可能的机制,通过这种机制,成年海马神经元可能发挥了它们的作用。我们的结果通过表明增加 AHN 不仅可以在暴露于应激之前,而且可以在暴露于应激之后通过抵消其几种作用来对抗应激,部分通过调节 HPA 轴,为抑郁症的神经发生假说做出了贡献。